BXDIF
BROOKFIELD Corp /ON/
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
May 26, 2026
SEC
Brookfield Corporation and Brookfield Wealth Solutions received board approval for a corporate simplification transactio
6-K — Impact 5/10
May 14, 2026
SEC
Brookfield Corp reported solid Q1 2026 results with distributable earnings before realizations up 7% YoY to $1.393B. The
6-K — Impact 6/10
Apr 22, 2026
SEC
Brookfield Corporation and its subsidiary Brookfield Finance II Inc. issued a new $500 million bond series due 2036 with
6-K — Impact 3/10
Analyst Ratings
3Strong Buy
14Buy
2Hold
0Sell
1Strong Sell
Latest Reports
NEUTRAL
6-K
5/10
Brookfield Corporation and Brookfield Wealth Solutions received board approval for a corporate simplification transactio
May 26, 2026
BULLISH
6-K
6/10
Brookfield Corp reported solid Q1 2026 results with distributable earnings before realizations up 7% YoY to $1.393B. The
May 14, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 4.7/10.
NEUTRAL
6-K
5/10
Brookfield Corporation and Brookfield Wealth Solutions received board approval for a corporate simpl
May 26, 2026
BULLISH
6-K
6/10
Brookfield Corp reported solid Q1 2026 results with distributable earnings before realizations up 7%
May 14, 2026
NEUTRAL
6-K
3/10
Brookfield Corporation and its subsidiary Brookfield Finance II Inc. issued a new $500 million bond
Apr 22, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 85% buy across 20 analysts — 3 strong buy, 14 buy, 2 hold, 0 sell, 1 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 14 | 2 | 0 | 1 | 85% | |
| May 1, 2026 | 3 | 12 | 3 | 0 | 1 | 79% | |
| Apr 1, 2026 | 3 | 12 | 3 | 0 | 1 | 79% | |
| Mar 1, 2026 | 3 | 12 | 3 | 0 | 1 | 79% | |
| Feb 1, 2026 | 3 | 12 | 3 | 0 | 1 | 79% | |
| Jan 1, 2026 | 3 | 12 | 3 | 0 | 1 | 79% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.